Biovian is a dynamic and effective new generation one-stop-shop contract manufacturing organisation (CMO) in current good manufacturing practice (cGMP) contract manufacturing of biopharmaceuticals.
Biovian’s services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.
Biovian’s certified 2,700m2 cGMP facilities contain EU grade A, B, C and D class cleanrooms and warehouses under full quality control, as well as extensively equipped development laboratories.
Biovian is a privately-owned, independent company entirely focused on customer projects and specialising in process development, scale-up and cGMP contract manufacturing of biopharmaceuticals.
Biovian holds EMEA cGMP manufacturing authorisation for investigational and commercial use.
Biovian’s cGMP services include:
• Mammalian cell culture
• Viral vector production
• Protein purification
• Fill and finish
• Analytical quality control services
• Stability studies
• Master cell banks (MCB) / working cell banks (WCB) preparation and storage
• Sterility testing
• Gene therapy production
Biovian’s process development services include:
• Cell line development
• Cultivation development
• cGMP protein purification development
• Analytical development
• Proteins for research purposes
• Master cell bank manufacturing
Tykistökatu 6 A
Phone: +358 2 2748 840
Director, business development and projects